Getting a liver transplant is genuinely difficult. In 2016, over 12,300 patients were added to the U.S. liver transplant waitlist, but only about 7,335 received one. Nearly 2,900 patients died or became too sick and were removed from the list that same year without ever getting a new liver. The process involves a rigorous medical and psychosocial evaluation, a scoring system that ranks you against every other person waiting, and wait times that vary dramatically depending on where you live.
How the Priority System Works
Liver transplants in the U.S. are allocated based on medical urgency, not how long you’ve been waiting. The system uses the MELD score (Model for End-Stage Liver Disease), which ranges from 6 to 40 and predicts your risk of dying in the next three months without a transplant. A higher score means you’re sicker and get priority. When a donor liver becomes available, it goes to the person in the region with the highest MELD score who is a compatible match.
This creates a difficult paradox: you need to be sick enough to score high on the list, but healthy enough to survive a major surgery. People with moderate liver disease can spend months or years on the waitlist because their scores aren’t high enough to compete with the sickest patients. Some people with conditions the MELD score doesn’t capture well, like liver cancer, can qualify for exception points that bump up their priority regardless of their lab numbers.
Where You Live Changes Your Wait
Geography plays a surprisingly large role. The country is divided into transplant regions, and organ availability varies widely between them. In regions with short wait times, the median wait was about 1 to 2.3 months between 2010 and 2014. In long-wait regions, that number jumped to 11.6 months. That gap has been widening over time. In the early study period (2005 to 2009), long-wait regions had a median of 5.6 months, meaning waits roughly doubled over five years in those areas.
About a third of listed patients are in long-wait regions, and nearly a quarter are in the shortest-wait regions. Some patients choose to list at transplant centers in different regions to improve their odds, though this adds complexity in terms of travel and logistics.
The Evaluation Before You’re Listed
Before you even get on the waitlist, you go through an extensive evaluation that can take weeks or months. Transplant centers assess your overall health to determine whether you can survive the surgery and maintain the organ afterward. The evaluation has both medical and non-medical components.
On the medical side, certain conditions will disqualify you. These include advanced heart or lung disease, active cancer outside the liver, active severe infections, and certain types of bile duct cancer. Each of these makes the risks of transplant surgery outweigh the benefits.
The non-medical side is where things get more complicated. Transplant teams typically require you to demonstrate social support: people who can help with transportation, managing medications, and monitoring symptoms after surgery. These requirements vary significantly from one transplant center to another, and some programs require multiple caregivers to be available for extended periods. This can be a real barrier for patients who live alone or lack a strong support network. The national organ-sharing network has stated that access to transplant should not depend on having social support, and that programs should work to ensure equitable access, but in practice, individual centers still set their own standards.
Financial considerations also play a role. While transplant centers don’t publish explicit income requirements, the cost of lifelong anti-rejection medications, follow-up appointments, and potential time off work creates real obstacles. Insurance coverage, out-of-pocket costs, and the ability to afford post-transplant care all factor into the evaluation at many programs.
Alcohol-Related Liver Disease and Sobriety Rules
For patients whose liver failure is related to alcohol use, an additional hurdle has historically applied: the six-month sobriety rule. First introduced in 1984, this requirement demanded verified abstinence for at least six months before a patient could be listed. The rationale was twofold: it allowed the liver time to recover from acute alcohol-related inflammation, and it was seen as a predictor of long-term sobriety.
This rule is now being widely reconsidered. Research has shown a poor correlation between the length of pre-transplant abstinence and whether someone drinks again after transplant. One study found that while the six-month benchmark had about 80% sensitivity, its specificity was only 40%, meaning it was not a reliable predictor on its own. The rule also created measurable inequities: Black patients and women with alcohol-related liver disease had higher rates of dying while listed, suggesting unequal access to transplantation.
A landmark study demonstrated that carefully selected patients with severe alcohol-related hepatitis could successfully undergo transplantation without meeting the traditional six-month requirement. Many transplant centers have since moved toward comprehensive, individualized assessments that include validated psychological tools, alcohol biomarker testing, and multidisciplinary evaluation rather than a rigid time-based rule. The shift is ongoing, and practices still vary between centers.
What Happens After Transplant
For those who do receive a liver, outcomes are relatively good. About 92% of adult recipients survive at least one year, and roughly 81% survive five years. Ten-year survival is around 64%. Most of the risk is concentrated in the first six months, when about 5.7% of recipients die, often from surgical complications or early organ rejection.
Long-term survival depends on consistently taking anti-rejection medications, attending follow-up appointments, and managing other health conditions. The transplanted liver can last decades, but it requires lifelong medical care.
Living Donor Transplants
One option that can bypass much of the waitlist challenge is a living donor transplant. The liver is unique in its ability to regenerate. A healthy person can donate a portion of their liver, and both the donor’s remaining liver and the transplanted piece will grow back to near-normal size within weeks to months. This eliminates the need to wait for a deceased donor and allows surgery to be scheduled at an optimal time rather than as an emergency when an organ becomes available.
Living donor transplants aren’t simple, though. The donor undergoes major abdominal surgery with its own risks, and not every potential donor is a match. Donors must pass their own rigorous medical and psychological evaluation. Still, for patients with a willing and compatible donor, this path significantly reduces the difficulty of getting a transplant and can be life-saving for people whose MELD scores aren’t high enough to compete for deceased donor organs.